Ellevest, Inc. Krystal Biotech, Inc. Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$72.39 - $84.27 $1,447 - $1,685	20 Added 15.38%	150 $12,000
Q4 2022 Feb 03, 2023	SELL	$63.14 - $79.9 $505 - $639	-8 Reduced 5.8%	130 $10,000
Q3 2022 Nov 02, 2022	BUY	$64.85 - $82.4 $6,225 - $7,910	96 Added 228.57%	138 $10,000
Q2 2022 Jul 18, 2022	BUY	$48.93 - $73.47 $2,055 - $3,085	42 New	42 $3,000

311

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.05B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.